Gene Query: CYTH3

Dataset Description Geneva Score
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 53.29
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 52.71
circRNA-sequencing 41.15
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 40.8
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 39.42
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 39.42
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 33.98
SUV420H2 knockdown in PANC-1 33.74
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 32.39
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 30.36
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 28.81
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 28.69
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 27.1
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 26.43
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 26.4
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 26.05
TCF7L1 knockdown in pancreatic cancer 24.26
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 23.56
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 23.32
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 23.12
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 22.97
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 22.97
Dtx3L and Androgen Signaling in Prostate Cancer 22.67
G-quadruplex structures mark human regulatory chromatin 22.3
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 22.04
Survival of pancreatic cancer cells lacking KRAS function 21.83
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 21.02
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 20.88
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 20.33
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 20.3
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 20.3
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 19.43
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 19.34
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 19.23
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 18.81
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 18.76
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 18.6
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 18.44
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 18.44
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 18.3
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 18.04
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 17.81
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 17.34
Toxoplasma gondii infection of human retinal pigment epithelial cells 17.2
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 17.18
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 16.96
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 16.96
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 16.93
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 16.91
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 16.84
Intrahepatic MAIT cell gene expression revealed by RNA-seq 16.68
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 16.28
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 16.24
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 16.22
Paxillin regulates genomic networks in prostate cancer [C4-2] 16.14
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 16.14
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 15.92
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 15.86
Identification of differentially expressed genes between senescence and senescence bypass cells 15.85
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 15.84
UBC9 knockdown in bladder cancer T24 cell lines 15.82
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 15.8
IL-33 activates tumor stroma to promote intestinal polyposis 15.56
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 15.3
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 15.3
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 15.03
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 14.97
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 14.92
hTERT promotes cell adhesion and migration independent of telomerase activity 14.49
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 14.47
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 14.47
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 14.38
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 14.37
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 14.33
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 14.17
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 14.16
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 14.16
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 14.09
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 13.93
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 13.74
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 13.7
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 13.7
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 13.48
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 13.48
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 13.37
PGE2 mediated gene expression changes in human cervical stromal cells 13.33
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 13.29
Transcriptome analysis of virus infected tissues 13.29
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 13.28
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 13.25
Nucleoporin-mediated regulation of cell identity genes 13.18
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 13.11
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 13.11
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 12.99
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 12.99
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 12.97
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 12.8
High-efficiency RNA-based reprogramming of human primary fibroblasts 12.8
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 12.72
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 12.62
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 12.6
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 12.55
A549 cells and MSR-A549 cells 12.55
Transcriptome of activated human and mouse MAIT cells 12.49
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 12.46
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 12.46
RNA-seq of YB5 cells treated with Proscillaridin A 12.45
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 12.44
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 12.41
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 12.35
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 12.17
Control of prostate tumour growth by the long non-coding RNA GHSROS 12.1
CHD1 regulates cell fate determination by activation of differentiation-induced genes 12.07
RNA-seq analysis of uveal melanoma cells treated with FR900359 12.07
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 11.86
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 11.76
Transcriptomic analysis of LSD1 11.66
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.62
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 11.55
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 11.55
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 11.55
Chromatin-informed inference of transcriptional programs in gynecologic cancers 11.55
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 11.37
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 11.37
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 11.34
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 11.26
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 11.26
Genetic-to-epigenetic Therapy for Pancreatic Cancer 11.08
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 11.06
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 10.99
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 10.96
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 10.95
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 10.95
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 10.94
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 10.89
An siRNA screen identifies CHD4 as a target for epigenetic therapy 10.88
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 10.75
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 10.75
MicroRNA targetome analysis during HCMV infection 10.59
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 10.57
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 10.53
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 10.45
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 10.36
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 10.36
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 10.27
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 10.27
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 10.18
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 10.18
Investigation about fibroblasts of different origins in culture 10.13
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 10.13
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 10.07
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 10.04
mRNA sequencing of oropharyngeal cancer cell lines 10.02
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 10.01
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.98
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 9.92
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 9.91
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 9.91
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 9.86
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.82
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.82
A sister of NANOG regulates genes expressed in pre-implantation human development 9.8
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 9.77
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 9.77
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.77
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.77
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 9.77
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 9.69
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 9.68
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 9.68
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.64
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.62
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 9.6
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 9.56
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 9.56
EGR1-controlled transcriptome of T HESCs 9.55
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.49
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 9.39
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 9.36
The evolution of N6-methyladenosine in primates 9.35
BAF controls genome accessibility 9.27
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.26
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.26
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 9.25
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 9.22
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 9.22
Ro60-knockout cells 9.21
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 9.16
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 9.15
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 9.14
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 9.14
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 9.13
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 9.08
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 9.08
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 9.07
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.07
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.07
Lysine benzoylation is a novel histone mark [RNA-seq] 9.01
Lysine benzoylation is a novel histone mark 9.01
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 8.9
Disruption of the exocyst induces podocyte loss and dysfunction 8.86
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 8.83
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 8.76
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 8.73
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 8.73
Evolution of a transcriptional regulator from a transmembrane nucleoporin 8.71
RNA-seq in HepG2 and IMR90 cells 8.71
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 8.68
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 8.68
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 8.63
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 8.61
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 8.59
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.53
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.53
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 8.51
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 8.51
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 8.47
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 8.46
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 8.4
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 8.37
Transcriptomic profiling of human peripheral blood-derived mast cells 8.37
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 8.36
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 8.36
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 8.35
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 8.33
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 8.29
X-Ray induced DNA-Hydroxymethylation changes 8.28
RNA seq comparison between scrambled and shGRP78 cells 8.25
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.18
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 8.13
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.12
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 8.02
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 8.02
Regulation of protein translation during mitosis 7.94
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 7.92
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 7.85
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 7.85
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 7.85
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 7.85
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 7.84
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 7.79
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 7.79
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 7.78
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 7.78
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 7.72
RNA-seq of shEZH2 cells 7.72
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 7.72
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 7.66
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.63
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.56
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.53
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 7.53
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.48
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 7.47
The cytokine environment influence on human skin-derived T cells 7.46
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 7.43
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 7.35
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 7.35
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.33
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 7.32
MRTF activates TEAD-YAP target gene expression 7.31
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 7.25
High level DNA repair gene expression in human ES cells 7.19
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 7.13
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 7.1
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 7.05
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 7.04
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 7.03
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 7.01
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 6.96
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 6.96
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 6.93
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 6.92
Downregulation of LATS kinases alters p53 to promote cell migration 6.92
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 6.9
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 6.9
Differential gene expression in Jagged1 treated human dental pulp cells. 6.89
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.88
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 6.87
HNRNPL and its RNA Targets in Prostate Cancer 6.85
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 6.85
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 6.84
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 6.84
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 6.81
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 6.81
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 6.8
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 6.77
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.76
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 6.75
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 6.74
Seletive inhibition of CDK9 in DLBCL cell lines 6.65
Generation of trichogenic adipose-derived stem cells by expression of three factors 6.64
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 6.63
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 6.53
GATA3-mediated chromatin reprogramming in breast cancer cells 6.53
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 6.5
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 6.48
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 6.48
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 6.48
Generation of KRAS signatures using immortalized isogenic lung cells. 6.43
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 6.35
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 6.35
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 6.34
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 6.27
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 6.23
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 6.19
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.18
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.18
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 6.13
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 6.08
Genome-wide chromatin analysis of Ewing sarcoma 6.03
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 6.03
mRNA differential expression analysis in a human ex vivo model of chronic wounds 5.99
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.99
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 5.97
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 5.92
Aortic Valve Tissue: Stenosis vs. Sclerosis 5.86
Gene expression in GBM with Cav3.2 inhibition 5.85
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 5.85
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 5.82
Role of COP1 on MAP kinase transcriptional output in melanoma 5.77
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 5.65
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 5.62
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 5.61
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.6
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.46
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 5.46
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 5.42
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.4
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 5.38
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 5.38
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.38
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 5.28
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.28
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.28
Redifferentiation of expanded human islet β cells by inhibition of ARX 5.26
Modeling Familial Cancer with iPSC Approaches 5.23
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 5.14
Real-time observation of light-controlled transcription in living cells 5.14
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 5.14
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 5.14
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.14
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 5.08
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.97
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.97
Effect of drugs on transcriptomic profiles 4.93
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 4.86
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 4.86
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.8
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.79
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.79
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 4.76
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 4.75
Gene expression profile in breast cancer cells 4.75
iPSC-Derived Cholangiocytes 4.75
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.74
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.72
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.7
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 4.65
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 4.65
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 4.57
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 4.53
RNA sequencing analysis of selumetinib-resistant CRC cells lines 4.51
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 4.5
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 4.5
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 4.45
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 4.45
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.43
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.43
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.41
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 4.38
Effect of nuclear IL-33 on gene expression 4.37
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.35
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 4.28
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.2
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.09
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.98
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 3.97
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 3.97
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.91
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.91
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.87
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.85
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 3.85
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.85
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.8
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.71
Mapping interactions for the TNIP2 hub protein 3.71
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.48
6mer seed toxicity in viral microRNAs 3.46
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.42
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.42
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.42
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.4
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 3.37
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.36
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.36
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.34
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.31
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.3
Transcriptomic analysis of ERR alpha orphan nuclear receptor 3.28
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.27
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 3.24
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 3.23
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 3.23
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.15
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.15
UV_24h_GRO-Seq 3.01
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.97
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.84
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.83
MHC Transcriptomic landscape at haplotype-specific resolution 2.65
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.65
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.63
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.62
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.61
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.58
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.54
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 2.51
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.47
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.47
A prostate cancer chromatin interaction map 2.41
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 2.4
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.38
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.34
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 2.3
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.29
Transcriptome of EBV-infected gastric cancer cell lines 2.25
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.14
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.14
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.12
Metabolism as an early predictor of DPSCs aging 2.05
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.0
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.91
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.88
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.88
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.88
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.86
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.76
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.72
Effects of transcription on genome - nuclear lamina interactions 1.65
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.65
RNA splicing alteration on glioblastoma and normal neural stem cells 1.61
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.56
Fusion discovery in breast cancer cell line 1.56
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 1.46
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 1.44
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 1.44
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.43
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.43
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.42
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.35
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.35
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.33
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.32
HNRNPM-regulated splicing dependencies in prostate cancer 1.32
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.27
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.19
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.18
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.18
Characterization of human ILC2 subsets 1.15
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 1.14
Finding missing proteins from epigenetically manipulated human cells 1.13
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.12
The circadian transcriptional landscape in primary human mammary epithelial cells 1.11
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 1.11
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.04
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.02
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.97
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.97
Transposon-based construction of strand-specific RNA-seq libraries 0.91
FOXP2's impact on the primate transcriptome 0.88
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.86
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.86
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.8
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.8
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.8
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.77
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.76
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.76
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.68
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.68
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.64
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.44
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.43
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.34
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.32
MAIT cell RNA sequencing 0.17
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.14
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.14
CDK4/6 inhibitor resistance in prostate cancer 0.11
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.09
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.09
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.07
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.05
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.05
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.04
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation